The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in patients (pts) with nonmetastatic, biochemically relapsed prostate cancer (BRPC): Results of the interim analysis of a prospective phase II study.
 
Daniel Keizman
Honoraria - Bayer; Janssen Oncology; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Pfizer; Sanofi
 
Moshe A. Frenkel
No Relationships to Disclose
 
Todd Michael Edwards
No Relationships to Disclose
 
Eli Rosenbaum
No Relationships to Disclose
 
David Margel
No Relationships to Disclose
 
David Sarid
No Relationships to Disclose
 
Victoria Neiman
No Relationships to Disclose
 
Maya Gottfried
No Relationships to Disclose
 
Natalie Maimon
No Relationships to Disclose
 
Ilan Leibovitch
No Relationships to Disclose
 
Hadas Dresler
No Relationships to Disclose
 
Isaac Eliaz
No Relationships to Disclose